Tuesday, September 8, 2015

Pacira sues FDA over pain drug marketing restrictions

NEW YORK (Reuters) - Pacira Pharmaceuticals Inc on Tuesday filed a lawsuit seeking a court order allowing it to promote its post-surgery pain drug, Exparel, for a wide range of surgeries, which the U.S. Food and Drug Administration opposes.











Latest health news from http://reuters.us.feedsportal.com/c/35217/f/654207/s/49ae397e/sc/7/l/0L0Sreuters0N0Carticle0C20A150C0A90C0A90Cus0Epacirapharma0Efda0Elawsuit0EidUSKCN0AR82PI20A150A90A90DfeedType0FRSS0GfeedName0FhealthNews/story01.htm

No comments:

Post a Comment